# Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas

> **NCT02368197** · PHASE2,PHASE3 · TERMINATED · sponsor: **Shaare Zedek Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Dialysis Access Dysfunction

## Interventions

- **DRUG:** paclitaxel (Cardionovum Legflow drug eluting balloon)
- **DEVICE:** Balloon angioplasty (Bard Dorado)

## Key facts

- **NCT ID:** NCT02368197
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368197, "Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02368197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*